In a recent study based on in vivo and in vitro analyses, Elcheva et al. [32] found evidence of a significant correlation between IGF2BP1 and the aggressiveness of leukemia, through the persistence of tumorigenicity by increasing critical transcriptional and metabolic regulators. Here, IGF2BP1 is linked to leukemia.